Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/03/2857343/0/en/Solid-Biosciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/04/01/2855112/0/en/Solid-Biosciences-Receives-Rare-Pediatric-Disease-Designation-from-the-FDA-for-Duchenne-Muscular-Dystrophy-Gene-Therapy-Candidate-SGT-003.html
https://www.globenewswire.com/news-release/2024/03/27/2853038/0/en/Solid-Biosciences-to-Participate-at-Cantor-s-Virtual-Muscular-Dystrophy-Symposium.html
https://www.globenewswire.com//news-release/2024/03/13/2845337/0/en/Solid-Biosciences-Provides-Fourth-Quarter-and-Full-Year-2023-Business-Update-and-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/07/2842105/0/en/Solid-Biosciences-Announces-Licensing-Agreement-with-Armatus-Bio-for-the-Use-of-AAV-SLB101-a-Proprietary-Muscle-Targeted-Capsid-in-the-Development-of-an-RNAi-Therapy-to-treat-FSHD.html
https://www.globenewswire.com//news-release/2024/03/06/2841383/0/en/Solid-Biosciences-to-Participate-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/16/2809854/0/en/Solid-Biosciences-Granted-FDA-Orphan-Drug-Designation-for-Duchenne-Muscular-Dystrophy-Gene-Therapy-Candidate-SGT-003.html
https://www.globenewswire.com//news-release/2024/01/08/2805306/0/en/Solid-Biosciences-Announces-109-Million-Private-Placement.html
https://www.globenewswire.com//news-release/2024/01/04/2803960/0/en/Solid-Biosciences-to-Participate-at-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/12/07/2792478/0/en/Solid-Biosciences-Receives-FDA-Fast-Track-Designation-for-Duchenne-Muscular-Dystrophy-Gene-Therapy-SGT-003.html